Harbour makes $90M upfront deal with Bristol Myers for new antibodies
Harbour makes $90M upfront deal with Bristol Myers for new antibodies
Body unavailable. Use the original source.
Harbour makes $90M upfront deal with Bristol Myers for new antibodies
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.